Research Article
Effects of Low-Dose Spironolactone Combined with Metformin or Either Drug Alone on Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Pilot Study
Table 4
Compliance among the three groups during 12 weeks of treatment.
| ||||||||||||||||||||||||||||||||||||
MET: metformin; SPI: spironolactone; COM: combined. |